New Antiviral Drug Cuts Cytomegalovirus Infection and Improves Survival in Patients Undergoing Donor Stem Cell Transplant
Dana-Farber Cancer InstituteIn a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute has shown that a novel agent can protect against the most common viral infection that patients face after transplantation.